Neogen (NEOG) Free Cash Flow (2010 - 2026)
Neogen's (NEOG) quarterly Free Cash Flow came in at $11.1 million in Q1 2026, up 182.34% year-on-year from $3.9 million in Q1 2025, and up 42.43% quarter-over-quarter from $7.8 million in Q4 2025.
Neogen (NEOG) Free Cash Flow (2010 - 2026) Analysis & Trends
Neogen's Free Cash Flow history runs 17 years deep, the most recent figure standing at $11.1 million for Q1 2026.
- On a quarterly basis, Free Cash Flow rose 182.34% year-over-year to $11.1 million in Q1 2026; TTM through Feb 2026 was $6.0 million, a 113.68% increase from a year earlier, with the FY2025 full-year figure at -$46.4 million, up 39.14% from the prior year.
- Free Cash Flow advanced to $11.1 million in Q1 2026 per NEOG's latest filing, from $7.8 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $65.5 million in Q2 2023 and bottomed at -$62.3 million in Q1 2024.
- The 5-year median for Free Cash Flow is -$7.6 million (2023), against an average of -$7.9 million.
- Biggest YoY gain for Free Cash Flow was 733.7% in 2023; the steepest drop was 49469.23% in 2023.
- Year by year, Free Cash Flow stood at -$30.8 million in 2022, then jumped by 71.78% to -$8.7 million in 2023, then soared by 365.41% to $23.1 million in 2024, then sank by 66.34% to $7.8 million in 2025, then jumped by 42.43% to $11.1 million in 2026.
- Per Business Quant, the three latest NEOG Free Cash Flow figures stand at $11.1 million (Q1 2026), $7.8 million (Q4 2025), and -$13.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 449.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 305.56 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 112.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neogen | 2.09 Bn | 1.93 Bn | 99.00 Mn | 11.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 11.07 Mn |
| Feb 28, 2026 | 11.07 Mn |
| Nov 30, 2025 | 7.78 Mn |
| Nov 30, 2025 | 7.78 Mn |
| Aug 31, 2025 | -13.15 Mn |
| Aug 31, 2025 | -13.15 Mn |
| May 31, 2025 | 349,000.00 |
| May 31, 2025 | 349,000.00 |
| Feb 28, 2025 | -13.45 Mn |
| Feb 28, 2025 | -13.45 Mn |
| Nov 30, 2024 | 23.10 Mn |
| Nov 30, 2024 | 23.10 Mn |
| Aug 31, 2024 | -56.35 Mn |
| Aug 31, 2024 | -56.35 Mn |
| May 31, 2024 | 2.49 Mn |
| May 31, 2024 | 2.49 Mn |
| Feb 29, 2024 | -62.33 Mn |
| Feb 29, 2024 | -62.33 Mn |
| Nov 30, 2023 | -8.70 Mn |
| Nov 30, 2023 | -8.70 Mn |